NDLI: TZDs and Bone: A Review of the Recent Clinical Evidence

Content Provider	PubMed Central
Author	Schwartz, Ann V.
Copyright Year	2008
Abstract	Over the past two years, evidence has emerged that the currently available thiazolidinediones (TZDs), rosiglitazone, and pioglitazone have negative skeletal consequences, at least in women, which are clinically important. Increased fracture risk in women, but not men, was reported for both TZDs, based on analyses of adverse event reports from clinical trials. In short-term clinical trials in women, both TZDs caused more rapid bone loss. In these trials, changes in bone turnover markers suggest a pattern of reduced bone formation without a change in resorption. Although limited, these results support the hypothesis based on rodent and in vitro models that reduced bone formation resulting from activation of peroxisome proliferator-activated receptor-γ (PPARγ) is a central mechanism for TZDs' effect on bone. Research is needed to better understand the mechanisms of bone loss with TZDs, to identify factors that influence susceptibility to TZD-induced osteoporosis, and to test treatments for its prevention.
Related Links	http://dx.doi.org/10.1155/2008/297893
Starting Page	297893
File Format	PDF
ISSN	16874757
e-ISSN	16874765
Journal	PPAR Research
Volume Number	2008
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2008-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Pharmacology (medical) Drug Discovery Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Drug Discovery Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence.

The biological effects of tocotrienol on bone: a review on evidence from rodent models

A Systematic Review of Recent Advances in Equine Influenza Vaccination

PPARs and Bone Metabolism

Fine-Tuning Reception in the Bone: PPARγ and Company

Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms

Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma

TZDs and Bone: A Review of the Recent Clinical Evidence

Similar Documents

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence.

The biological effects of tocotrienol on bone: a review on evidence from rodent models

A Systematic Review of Recent Advances in Equine Influenza Vaccination

PPARs and Bone Metabolism

Fine-Tuning Reception in the Bone: PPARγ and Company

Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms

Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma

TZDs and Bone: A Review of the Recent Clinical Evidence